“INDICATIONS
Prevention of vitamin D deficiency and conditions resulting from vitamin D deficiency (e.g. osteomalacia, osteoporosis) in adults with obesity (body mass index [BMI] ≥ 30 kg/m2)
CONTRAINDICATIONS
Hypersensitivity to the active substance (cholecalciferol) or to any of the excipients.
Hypercalcemia and/or hypercalciuria.
Kidney stones and/or severe renal failure.
Pseudohypoparathyroidism (the need for vitamin D may be reduced due to periods of normal sensitivity to this vitamin, leading to an overdose). In this case, more manageable vitamin D derivatives are available.”
